Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Yijia Chu

Pain Medicine Grand Rapids, MI Medical Doctor

NPI 1538487673 CMS profile 1364438

1900 Wealthy St Se Ste 300, Grand Rapids, MI 49506

Open in the dashboard

General payments

$88,436

283 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Yijia Chu of Grand Rapids, MI is reported in the CMS Open Payments database as having received $88,436 across 283 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,221 86
2024 General $14,567 44
2023 General $11,866 46
2022 General $8,242 44
2021 General $3,987 26
2020 General $12,274 20
2019 General $6,280 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Yijia Chu
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Yijia Chu were reported at $31,221. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Yijia Chu Pain Medicine median Middle half National median
2019 $6,280 $498 $126–$1,682 $163
2020 $12,274 $284 $80–$910 $114
2021 $3,987 $399 $112–$1,219 $132
2022 $8,242 $455 $137–$1,484 $149
2023 $11,866 $484 $128–$1,495 $160
2024 $14,567 $498 $131–$1,540 $164
2025 $31,221 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $46,697 146 payments
  2. Boston Scientific Corporation $38,305 96 payments
  3. Relievant Medsystems, Inc. $985 10 payments
  4. Vertos Medical, Inc. $955 6 payments
  5. Stryker Corporation $669 8 payments
  6. Medtronic, Inc. $364 9 payments
  7. Nevro Corp. $204 2 payments
  8. SPR Therapeutics, Inc $104 1 payment
  9. Spinal Simplicity, LLC $50 1 payment
  10. Edwards Lifesciences Corporation $32 1 payment
  11. Other $72 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $31,418 19 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,960 27 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $12,934 10 payments
  4. Travel and Lodging $10,760 40 payments
  5. Food and Beverage $8,334 182 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $5,950 4 payments
  7. Education $81 1 payment
Products named General payments · program years 2019–2025
  1. PROCLAIM Neuromodulation $13,932 53 payments
  2. Neuromodulation Dspsbls and Accs $11,725 7 payments
  3. PROCLAIM Structural Heart $7,877 15 payments
  4. General - Therapies $7,424 9 payments
  5. PROCLAIM Neuromodulation $6,736 21 payments
  6. WaveWriter Alpha Prime 16 $6,534 8 payments
  7. Intracept $5,700 16 payments
  8. SPECTRA WAVEWRITER $5,343 10 payments
  9. Proclaim DRG IPG $2,723 6 payments
  10. PROCLAIM Structural Heart $2,579 7 payments
  11. Other $7,359 124 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

122

Median for Anesthesiology: 322

Drug cost

$826

Median for Anesthesiology: $8,738

Branded share of claims

50.8%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 39 $298
Gabapentin Generic 12 $155
Duloxetine Hcl Generic 14 $145
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 23 $98
Cephalexin Generic 23 $65
Oxycodone Hcl Generic 11 $64

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$184,741

Of which drugs: $1,444

Medicare patients

175

Average age 71

Services billed

15,184

97 women, 78 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Depression 39%
Ischemic heart disease 31%
Diabetes 27%
Chronic kidney disease 22%
Atrial fibrillation 18%
Cancer 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, ropivacaine hydrochloride, 1 mg J2795 Office 60 12,317 $639
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 104 712 $533
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 66 1,040 $91
Injection, fentanyl citrate, 0.1 mg J3010 Office 66 98 $70
Injection, cefazolin sodium, 500 mg J0690 Office 18 74 $46
Infusion, normal saline solution, sterile (500 ml = 1 unit) J7040 Office 18 29 $29
Injection, midazolam hydrochloride, per 1 mg J2250 Office 69 220 $24

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

283 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record